Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer

Unfortunately in the original publication of the article, the author’s funding support has been mentioned incorrectly. The correct funding statement should read as “This work was supported by the Morgan Welch Inflammatory Breast Cancer Research Program, the State of Texas Rare and Aggressive Breast...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Breast cancer research and treatment 2019-07, Vol.176 (1), p.251-251
Hauptverfasser:	Lee, Jangsoon, Lim, Bora, Pearson, Troy, Choi, Kuicheon, Fuson, Jon A., Bartholomeusz, Chandra, Paradiso, Linda J., Myers, Thomas, Tripathy, Debu, Ueno, Naoto T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Correction Flow cytometry Inflammation Medical research Medicine Medicine & Public Health Metastases Metastasis Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!